|
Prescription Drug Search
Strengths available for Glivec:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Glivec:
- Albania
- Anguilla
- Australia
- Azerbaijan
- Belize
- Bosnia and Herzegovina
- Brazil
- Bulgaria
- Cayman Islands
- Croatia
- Cuba
- Dominican Republic
- Egypt
- Fiji
- Finland
- Georgia
- Germany
- Greenland
- Guadeloupe
- Guam
- Hong Kong
- Hungary
- India
- Iraq
- Jordan
- Korea, Republic of
- Latvia
- Lithuania
- Luxembourg
- Moldova, Republic of
- Netherlands
- Saudi Arabia
- Slovakia
- Sweden
- Tonga
- United Arab Emirates
- United Kingdom, UK
- United States, US
- Uruguay
- Venezuela
Latest news releases on Glivec:
Leading Anti-Cancer Drugs and Associated Market 2012-2022 - new market research report - Transworld News
Leading Anti-Cancer Drugs and Associated Market 2012-2022 - Glivec/Gleevec (Novartis): Glivec, known as Gleevec in the US, is a protein kinase inhibitor developed by Novartis. In 2001, Glivec was granted fast-track approval for treating chronic myeloid ...
Stroke: Imatinib may reduce the risk of tPA-associated bleeding - Xagena Medical News
Imatinib (Gleevec / Glivec ). The results have demonstrated that Imatinib greatly reduces the risk of tPA-associated bleeding in mice, even when tPA was given as late as five hours after the stroke had begun. The LICR team, in collaboration with the ...
Novartis to probe drug approval allegations - swissinfo
Novartis has also been in an ongoing fight to protect its rights over its Glivec drug. The panel recommended the government re-examine certain drugs that had been approved, investigate the "gross violation" of Indian laws it had uncovered, and take action ...
Compulsory licensing sets off a wave of price cuts in cancer drugs - Livemint.com
Novartis AG’s highly priced cancer drug imatinib for treating a kind of blood cancer, which was sold as Glivec, faced stiff competition in India after generic companies introduced cheaper versions following the Indian patent office’s decision in 2005 ...
Long-term access solutions for cancer patients - Global Nation
Also worth citing is Novartis Oncology Access (NOA), “an innovative shared-contribution access program” that evolved from the Glivec International Patient Assistance Program (Gipap). Launched in 2002, Gipap is a comprehensive direct-to-patient ...
